RBFOX3 and colorectal carcinoma: Kuwahara et al. (8) predicted the prognosis of patients with CRC by integrating CD4+ and FOX3+ cells and concluded that a low proportion of CD4+ and FOX3+ cells suggests a poor prognosis.